Semaglutide Study Initiated to Investigate Visceral Adipose Tissue and Liver Changes in CKD Patients
Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD
Abstract
A new study is recruiting patients to investigate how Semaglutide affects visceral adipose tissue and liver function in chronic kidney disease.